眼科

• 专家论坛 • 上一篇    下一篇

原发性闭角型青光眼发病机制和致病基因探索的新思路

余晓伟  杨雪  赵珍妮  范志刚   

  1. 中山大学中山眼科中心  眼科学国家重点实验室,广州510060
  • 收稿日期:2020-04-19 出版日期:2020-07-22 发布日期:2020-07-21
  • 通讯作者: 范志刚,Email:fanzhg3@mail.sysu.edu.cn
  • 基金资助:
    广州市民生科技攻关计划项目(201903010065);中山大学中山眼科中心资助项目(3030902113080);广东省自然科学基金(2020A151501168)

New concepts to explore the pathogenesis and pathogenic genes of primary angle-closure glaucoma

Yu Xiaowei, Yang Xue, Zhao Zhenni, Fan Zhigang   

  1. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
  • Received:2020-04-19 Online:2020-07-22 Published:2020-07-21
  • Contact: Fan Zhigang, Email: fanzhg3@mail.sysu.edu.cn
  • Supported by:
    Guangzhou Science and Technology Plan Project(201903010065); Zhongshan Eye Center of Sun Yat-sen University Project (3030902113080); Guangdong Natural Science Foundation (2020A151501168)
     

摘要: 原发性闭角型青光眼(primary angle-closure glaucoma,PACG)是多基因复杂异质性眼病。其解剖学本质为各种原因所致的房角机械性关闭。临床上原发性开角型青光眼合并房角狭窄及进行性关闭并不少见。如未审视疾病的连续动态进程,将导致临床和基础研究中研究对象的混杂,这是既往PACG发病机制研究的重要瓶颈之一。解剖学上房角机械性关闭在分子机制水平可分为眼轴的发育调控、前房角相关结构的发育调控(包括晶状体和悬韧带)、视网膜-脉络膜-巩膜的发育调控。目前研究显示,可能影响虹膜-睫状体-悬韧带-晶状体结构与发育的基因有CHAT、PLEKHA7、FEPMT2,可能影响视网膜-脉络膜-巩膜结构发育的基因有TMEM98、CRB1、BEST1,可能影响眼轴-眼球大小发育的基因有MFRP、ABCC5、PRSS56、MMP9、NOS3、HSP70,但这些基因功能与PACG发生发展相关的分子机制尚未完全阐明。在分子机制角度上真性小眼球是PACG的完全外显型,而临床PACG则是上述3类表型不同程度的组合。以真性小眼球为研究对象,最终将有望突破PACG的分子机制,从而实现PACG基于基因型的临床亚型分类。 (眼科,2020, 29: 246-254)

关键词: 原发性闭角型青光眼, 发病机制, 眼轴调控, 基因

Abstract:  Primary angle-closure glaucoma (PACG) is a group of complex polygenic and heterogeneous diseases, the essential pathogenesis of which is mechanical obstruction of trabecular meshwork by peripheral iris secondary to various etiologies. Clinically, the incidence of primary open-angle glaucoma (POAG) complicated by narrow angle and progressive synechia angle closure is not uncommon. If we do not deliberately scrutinize these clinical cases from the dynamic course of disease development, a confusion of clinical and basic research object could be made, which is probably an important reason that restricts the clinical and genetic studies of PACG pathogenesis due to an impure contamination of enrolled cases. From a molecular perspective, the mechanisms of anatomical angle closure can be categorized into regulation of development in ocular axial, regulation ofdevelopmentin anterior chamber angle structures, including lens and lens zonules and regulation of development in retina-choroid-sclera complex. Current studies reveal that genes which may affect the structure and development of the iris-ciliary body-lens zonules-lens are CHAT, PLEKHA7 and FEPMT2; genes that may affect the development of retina-choroid-sclera complex are TMEM98, CRB and BEST1 and genes thatmay affect ocular axial are MFRP, ABCC5, PRSS56, MMP9, NOS3 and HSP70. However, the molecular mechanism of these genes associated with the development of POAG is still unclear. Indeed, nanophthalmos can be considered a full disease spectrum of PACG, as it has all phenotypes of various clinical PACG subtypes. Therefore, investigation into the molecular mechanisms of nanophthalmos could work as an entry window into the black house of molecular mechanisms in PACG. Further, a systemic classification of PACG subtypes can be realized through a combination of genetic markers and biometric markers in PACG. (Ophthalmol CHN, 2020, 29: 246-254)

Key words: primary angle-closure glaucoma, pathogenesis, regulation of axial length, genetics